Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1137075616 | 11370756 | 16 | F | 201507 | 20160718 | 20150812 | 20160721 | EXP | CA-PFIZER INC-2015267425 | PFIZER | 55.00 | YR | F | Y | 0.00000 | 20160721 | OT | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1137075616 | 11370756 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | UNK | Y | 11719 | ||||||||||
1137075616 | 11370756 | 2 | I | ENBREL | ETANERCEPT | 1 | Subcutaneous | UNK | Y | 0 | |||||||||
1137075616 | 11370756 | 3 | SS | CELEBREX | CELECOXIB | 1 | UNK | 20998 | CAPSULE, HARD | ||||||||||
1137075616 | 11370756 | 4 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 2X/DAY | Y | 203214 | 5 | MG | TABLET | BID | |||||
1137075616 | 11370756 | 5 | SS | LYRICA | PREGABALIN | 1 | UNK | 21446 | CAPSULE, HARD | ||||||||||
1137075616 | 11370756 | 6 | SS | ARTHROTEC | DICLOFENAC SODIUMMISOPROSTOL | 1 | UNK | Y | 20607 | TABLET | |||||||||
1137075616 | 11370756 | 7 | SS | PREDNISONE. | PREDNISONE | 1 | UNK | Y | 0 | ||||||||||
1137075616 | 11370756 | 8 | SS | NAPROSYN | NAPROXEN | 1 | UNK | Y | 0 | ||||||||||
1137075616 | 11370756 | 9 | SS | APO-AMITRIPTYLINE | AMITRIPTYLINE HYDROCHLORIDE | 1 | UNK | Y | 0 | TABLET | |||||||||
1137075616 | 11370756 | 10 | SS | VOLTAREN | DICLOFENAC SODIUM | 1 | UNK | Y | 0 | ||||||||||
1137075616 | 11370756 | 11 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
1137075616 | 11370756 | 1 | Rheumatoid arthritis |
1137075616 | 11370756 | 2 | Rheumatoid arthritis |
1137075616 | 11370756 | 3 | Rheumatoid arthritis |
1137075616 | 11370756 | 4 | Rheumatoid arthritis |
1137075616 | 11370756 | 5 | Rheumatoid arthritis |
1137075616 | 11370756 | 6 | Rheumatoid arthritis |
1137075616 | 11370756 | 7 | Rheumatoid arthritis |
1137075616 | 11370756 | 8 | Rheumatoid arthritis |
1137075616 | 11370756 | 9 | Rheumatoid arthritis |
1137075616 | 11370756 | 10 | Rheumatoid arthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
1137075616 | 11370756 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
1137075616 | 11370756 | Asthenia | |
1137075616 | 11370756 | Condition aggravated | |
1137075616 | 11370756 | Drug ineffective | |
1137075616 | 11370756 | Drug interaction | |
1137075616 | 11370756 | Gastrooesophageal reflux disease | |
1137075616 | 11370756 | Muscle spasms | |
1137075616 | 11370756 | Pain | |
1137075616 | 11370756 | Pain in jaw | |
1137075616 | 11370756 | Product quality issue | |
1137075616 | 11370756 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
1137075616 | 11370756 | 1 | 2004 | 2015 | 0 | |
1137075616 | 11370756 | 2 | 2010 | 201507 | 0 | |
1137075616 | 11370756 | 4 | 20150724 | 201511 | 0 | |
1137075616 | 11370756 | 6 | 2004 | 2010 | 0 | |
1137075616 | 11370756 | 10 | 2004 | 2010 | 0 | |
1137075616 | 11370756 | 11 | 2004 | 0 |